CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,122 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 34,165 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 16,450 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 30,000 shares at $1.84 ($55,200)
Page 3 of 18 · 352 filings